Trials / Completed
CompletedNCT01044524
Study to Investigate ADME of 14C Labeled SLV334 After an i.v. Infusion
An Open Label Study to Determine ADME of 14C Labeled SLV334 and Its Metabolites After Single Intravenous Dose Infusion
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Solvay Pharmaceuticals · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study will investigate the absorption, distribution, metabolism and excretion after giving 2000 mg 14C-SLV334 via a 1-hour infusion. The absolute bioavailability will also be determined.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | SLV 334 | 2000 mg via i.v. solution |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2010-03-01
- Completion
- 2010-03-01
- First posted
- 2010-01-08
- Last updated
- 2010-09-17
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01044524. Inclusion in this directory is not an endorsement.